Steffen Paschen, MD is an expert in Neurology at University Hospital Schleswig-Holstein (Germany). Steffen Paschen has authored 112 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 4 of them ongoing. SLR score: 418 (community average: 125). How the SLR is computed.

LeadR Profile

Steffen Paschen, MD University Hospital Schleswig-Holstein Germany
418 ScienceLeadR Reputation 418
Network Map

Neurology

Subspecialties: Public Health - Surgery - Physical Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2015 - 2026

Source: PubMed

University Hospital Schleswig-Holstein

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 112

Citations

Citations: 3 024 1st author: 13 Last author: 7 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Disease Duration Differentiates Freezing of Gait Response to Subthalamic and Nigral Stimulation for Parkinson's Disease in an Exploratory Multicenter Controlled Trial.
PMID 42860886 — parkinson disease, gait, deep brain stimulation, therapeutics, substantia nigra, subthalamic nucleus
Mov Disord Clin Pract20260
Probabilistic mapping of tremor control and gait ataxia risk in deep brain stimulation.
PMID 41885955 — essential tremor, brain, tremor, gait, deep brain stimulation, ataxia, synaptic transmission, gait ataxia, demography
J Neural Transm (Vienna)20260
Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson's Disease.
PMID 41631726 — parkinson disease, brain, pathology, pathology, molecular, movement disorders, therapeutics, therapy delivery
Mov Disord20260
Focused ultrasound pallidothalamic tractotomy for Parkinson's disease: the field is moving fast.
PMID 41240929 — parkinson disease, nervous system
Lancet Neurol Top journal20250
Longitudinal Blood-Biomarker-Based Assessment of Brain Injury in Patients Undergoing Deep Brain Stimulation and Magnetic Resonance-Guided Focused Ultrasound.
PMID 41025386 — brain injuries, blood, serum, brain, biomarkers, movement disorders, deep brain stimulation, therapeutics
Mov Disord20250

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 5
Phase 4 1

By status:

Recruiting 3
Active not recruiting 1
Completed 1
Unknown 1

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 4

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
EMBRACE Tremor BiFUS
NCT06974916 — essential tremor, tremor, therapeutics
N/ARecruiting2025
A Prospective Randomized Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR guided Focused Ultrasound Subthalamotomy in Patients With Early Stage Parkinson s Disease
NCT06584383 — safety, parkinson disease, therapeutics
N/AActive not recruiting2024
STIMPulseControl Ancillary Speech Study
NCT06561919 — parkinson disease, conduct disorder, brain, disruptive, impulse control, and conduct disorders, deep brain stimulation, therapeutics, speech
N/ARecruiting2024
Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders STIMPulseControl
NCT06498349 — parkinson disease, conduct disorder, brain, disruptive, impulse control, and conduct disorders, deep brain stimulation, therapeutics, subthalamic nucleus
N/ARecruiting2024

LeadR Networks

Main global connection map